eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel

SUBMIT FEEDBACKfeedback icon

Comments


close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

Submit Support Ticket

t on the system-->

close this panel
‹‹ Go Back

Katherine Cauthen

Sandia National Laboratories



‹‹ Go Back

Gregory Lambert

Sandia National Laboratories



‹‹ Go Back

Patrick Finley

Sandia National Laboratories



‹‹ Go Back

David Ross

U.S. Department of Veterans Affairs



‹‹ Go Back

Maggie Chartier

U.S. Department of Veterans Affairs



‹‹ Go Back

Victoria J. Davey

U.S. Department of Veterans Affairs



�� Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

358 – Disparities and Other Important Issues in Health Policy Research

A Bayesian Meta-Analysis of the Effect of Alcohol Use on HCV-Treatment Outcomes with a Comparison of Resampling Methods to Assess Uncertainty in Parameter Estimates

Sponsor: Health Policy Statistics Section
Keywords: Bayesian meta-analysis, resampling, hepatitis C, alcohol, uncertainty quantification

Katherine Cauthen

Sandia National Laboratories

Gregory Lambert

Sandia National Laboratories

Patrick Finley

Sandia National Laboratories

David Ross

U.S. Department of Veterans Affairs

Maggie Chartier

U.S. Department of Veterans Affairs

Victoria J. Davey

U.S. Department of Veterans Affairs

Heavy alcohol use is associated with lower HCV treatment response rates in interferon-based therapies, and although health care providers recommend reducing or abstaining from alcohol use prior to treatment, many patients are not successful. This meta-analysis systematically summarizes the English-language literature up through June 30, 2014 on the relationship between alcohol use and HCV treatment outcomes, among patients who were not required to abstain from alcohol use in order to receive treatment. Seven articles studying 1,751 HCV-infected patients were identified. Log-ORs of HCV treatment response for heavy versus light alcohol use were calculated. We employed a Bayesian model to accommodate the small sample size. The summary estimate for the log-OR of HCV treatment response was -0.775 (CI -1.397, -0.236). We compare various resampling methods to assess the uncertainty in parameter estimates. Heterogeneity accounted for 60.28% of the variation among log-ORs, but meta-regression was unable to capture its sources. This meta-analysis confirms that heavy alcohol use is associated with decreased HCV treatment response compared to lighter levels of alcohol use.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2015 CadmiumCD